Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

445 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The Hippo pathway and human cancer.
Harvey KF, Zhang X, Thomas DM. Harvey KF, et al. Among authors: thomas dm. Nat Rev Cancer. 2013 Apr;13(4):246-57. doi: 10.1038/nrc3458. Epub 2013 Mar 7. Nat Rev Cancer. 2013. PMID: 23467301 Review.
Role of the retinoblastoma protein in differentiation and senescence.
Thomas DM, Yang HS, Alexander K, Hinds PW. Thomas DM, et al. Cancer Biol Ther. 2003 Mar-Apr;2(2):124-30. Cancer Biol Ther. 2003. PMID: 12750549 Review.
Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma.
Thomas DM, Johnson SA, Sims NA, Trivett MK, Slavin JL, Rubin BP, Waring P, McArthur GA, Walkley CR, Holloway AJ, Diyagama D, Grim JE, Clurman BE, Bowtell DD, Lee JS, Gutierrez GM, Piscopo DM, Carty SA, Hinds PW. Thomas DM, et al. J Cell Biol. 2004 Dec 6;167(5):925-34. doi: 10.1083/jcb.200409187. J Cell Biol. 2004. PMID: 15583032 Free PMC article.
An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development.
Cullinane C, Dorow DS, Kansara M, Conus N, Binns D, Hicks RJ, Ashman LK, McArthur GA, Thomas DM. Cullinane C, et al. Among authors: thomas dm. Cancer Res. 2005 Nov 1;65(21):9633-6. doi: 10.1158/0008-5472.CAN-05-2285. Cancer Res. 2005. PMID: 16266981
High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer.
Krypuy M, Newnham GM, Thomas DM, Conron M, Dobrovic A. Krypuy M, et al. Among authors: thomas dm. BMC Cancer. 2006 Dec 21;6:295. doi: 10.1186/1471-2407-6-295. BMC Cancer. 2006. PMID: 17184525 Free PMC article.
Molecular pathogenesis of osteosarcoma.
Kansara M, Thomas DM. Kansara M, et al. Among authors: thomas dm. DNA Cell Biol. 2007 Jan;26(1):1-18. doi: 10.1089/dna.2006.0505. DNA Cell Biol. 2007. PMID: 17263592 Review.
Adolescents and young adults with cancer: the challenge.
Thomas DM. Thomas DM. Palliat Support Care. 2007 Jun;5(2):173-4. doi: 10.1017/s1478951507070253. Palliat Support Care. 2007. PMID: 17578069 No abstract available.
RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.
Clark JC, Thomas DM, Choong PF, Dass CR. Clark JC, et al. Among authors: thomas dm. Cancer Metastasis Rev. 2007 Dec;26(3-4):675-83. doi: 10.1007/s10555-007-9093-8. Cancer Metastasis Rev. 2007. PMID: 17828469 Review.
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice.
Kansara M, Tsang M, Kodjabachian L, Sims NA, Trivett MK, Ehrich M, Dobrovic A, Slavin J, Choong PF, Simmons PJ, Dawid IB, Thomas DM. Kansara M, et al. Among authors: thomas dm. J Clin Invest. 2009 Apr;119(4):837-51. doi: 10.1172/JCI37175. Epub 2009 Mar 23. J Clin Invest. 2009. PMID: 19307728 Free PMC article.
Gender-specific activity of chemotherapy correlates with outcomes in chemosensitive cancers of young adulthood.
Khamly KK, Thursfield VJ, Fay M, Desai J, Toner GC, Choong PF, Ngan SY, Powell GJ, Thomas DM. Khamly KK, et al. Among authors: thomas dm. Int J Cancer. 2009 Jul 15;125(2):426-31. doi: 10.1002/ijc.24376. Int J Cancer. 2009. PMID: 19391136
445 results
Jump to page
Feedback